2015 Lipper Award

Janus Contrarian Fund (JSVAX)

Investing Opportunistically in Non-Consensus Equity Ideas



Inception Date2/29/2000
NAV (As of 11/27/15 )$19.36
Total Net Assets (As of 10/31/15)$3.40B
Annual Expense Ratio
(As of fiscal year end 9/30/14)
GROSS 0.89%
NET 0.89%

Performance (As of 9/30/15)
1 Year-10.68%
3 Year14.38%
5 Year8.38%
10 Year5.72%
Morningstar (As of 10/31/15)
CategoryLarge Blend
Style Box

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

Returns greater than one year are annualized.

Net expense ratios reflect the expense waiver, if any, Janus Capital has contractually agreed to through 2/1/16.

Quarterly Commentary - Q3 2015


Uncertainty about global economic growth and U.S. interest rates sparked volatility this quarter.

The Fund underperformed its benchmark during the period.

We continue to be encouraged about the fundamental improvements and changes taking place at the companies in our Fund.


Dan Kozlowski

Daniel R. Kozlowski, CFA

Fund Manager since 2011
Industry since 1999